{"entity":{"id":"nct00003456","kind":"trial","name":"Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme","aka":[],"tldr":"A phase 2 trial of Antineoplastons in Glioma & glioblastoma, run by Burzynski Research Institute, completed.","summary":"Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme is a phase 2 interventional study registered as NCT00003456 by Burzynski Research Institute, with 40 participants recorded, started 1995-03-14 and reaching its primary completion in 2004-12-07. Interventions recorded: Antineoplaston therapy (Atengenal + Astugenal). Conditions recorded: Glioblastoma Multiforme of Brain.\n\nLinked to the technology Antineoplastons because the registry's title names it (\"antineoplastons\") and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00003456","url":"https://clinicaltrials.gov/study/NCT00003456"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["glioblastoma"],"sections":[],"technologies":["antineoplastons"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00003456","phase":"2","setting":"Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Glioblastoma Multiforme","sponsor":"Burzynski Research Institute","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00003456/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"technology":[{"id":"antineoplastons","kind":"technology","name":"Antineoplastons (Burzynski clinic)","route":"/technologies/antineoplastons/"}]}}